CAPLIPOINT2024-10-012024-12-31 CAPLIPOINT2024-10-012024-12-31 CAPLIPOINT2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member CAPLIPOINT2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member CAPLIPOINT2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524742 CAPLIPOINT NOTLISTED Caplin Point Laboratories Limited Equity 2024-04-01 2025-03-31 2025-02-07 2025-01-31 INR Crores Third quarter 11:45:00 13:10:00 2025-02-07 2025-02-07 Not applicable Single segment Pharmaceutical Formulations 2024-10-01 2024-12-31 Unaudited Standalone 1852300000.00 288300000.00 2140600000.00 332900000.00 192400000.00 81900000.00 138900000.00 400000.00 60100000.00 332300000.00 1138900000.00 1001700000.00 0.00 1001700000.00 255500000.00 -900000.00 254600000.00 0.00 747100000.00 0.00 0.00 0.00 0.00 747100000.00 0.00 747100000.00 0.00 0.00 152000000.00 2 9.83 9.77 0.00 0.00 9.83 9.77 0.00 0.00 0.00 1) The above Consolidated Financial Results for the Quarter and Nine months ended December 31, 2024 have been reviewed and recommended by the Audit Committee and have been approved by the Board of Directors of the Company at their respective meetings held on February 7, 2025 and also reviewed by the Statutory Auditors. 2) The unaudited Consolidated Financial Results of the Company has been prepared in accordance with the Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 ( the Act ) read with relevant rules issued thereunder ( Ind AS ) and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3) The Company is engaged in the sole activity of carrying on the business of Pharmaceutical Formulations and therefore, has only one reportable segment in accordance with Ind AS 108 Operating Segments . Hence no separate segment reporting is applicable to the Company. Single segment 2024-04-01 2024-12-31 Unaudited Standalone 5788000000.00 933400000.00 6721400000.00 1023900000.00 597800000.00 207000000.00 377400000.00 800000.00 186800000.00 1012600000.00 3406300000.00 3315100000.00 0.00 3315100000.00 792700000.00 -7500000.00 785200000.00 0.00 2529900000.00 0.00 0.00 0.00 0.00 2529900000.00 1200000.00 2531100000.00 0.00 0.00 152000000.00 2 33.30 33.12 0.00 0.00 33.30 33.12 0.00 0.00 0.00 Other Expenses 332300000.00 Other Expenses 1012600000.00 0.00 1600000.00 0.00 0.00 0.00 400000.00